Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
FDA nominee sidesteps questions on abortion pill, agency layoffs and other issues
President Donald Trump’s pick to lead the Food and Drug Administration largely sidestepped questions Thursday from senators ...
FDA top lawyer resigns days after starting job
The U.S. Food and Drug Administration’s (FDA) chief counsel resigned two days after her appointment, according to a Thursday announcement from the agency. “Hilary K. Perkins has ...
US FDA's Top Lawyer Hilary Perkins Resigns Two Days Into Role
(Reuters) -The U.S. Food and Drug Administration's chief counsel, Hilary Perkins, has resigned, the federal agency said in a ...
FDA chief counsel who defended abortion pill access under Biden resigns two days into job
Recently selected Food and Drug Administration chief lawyer Hilary K. Perkins has resigned from the job, according to a post ...
Wisconsin Examiner11d
Trump nominee to head up FDA won’t make any commitments on abortion pill access
Makaray says he will review data on mifepristone and follow the research where it leads him, with no preconceived ideas about ...
National Catholic Register4d
Trump’s Top Lawyer at FDA Resigns After Outcry Over Record Defending Abortion Pill
As a trial lawyer with the Biden administration’s Department of Justice, Hilary Perkins defended access to the abortion pill ...
Boston Herald11d
FDA nominee sidesteps questions on abortion pill, agency layoffs and other issues
including the abortion pill mifepristone, which has been ensnared in politics since a 2021 decision by FDA making it available by mail. “I have no preconceived plans on mifepristone policy ...
U.S. News & World Report11d
FDA Nominee Sidesteps Questions on Abortion Pill, Agency Layoffs and Other Issues
FDA Nominee Sidesteps Questions on Abortion Pill, Agency Layoffs and Other Issues President Donald Trump’s pick to lead the Food and Drug Administration largely sidestepped questions Thursday ...